Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Receivables (2020 - 2023)

Silo Pharma's Receivables history spans 3 years, with the latest figure at $79200.0 for Q3 2023.

  • For Q3 2023, Receivables changed N/A year-over-year to $79200.0; the TTM value through Sep 2023 reached $79200.0, changed N/A, while the annual FY2022 figure was $72020.0, N/A changed from the prior year.
  • Receivables for Q3 2023 was $79200.0 at Silo Pharma, up from $68390.0 in the prior quarter.
  • Across five years, Receivables topped out at $79200.0 in Q3 2023 and bottomed at $47000.0 in Q4 2020.
  • The 3-year median for Receivables is $70205.0 (2022), against an average of $66652.5.